Noumea Biosciences Inc. — Form D
Noumea Biosciences Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-08. The offering totals $300K, of which $300K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-08
- Form: D
- Accession: 0001944596-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Minimum investment: $300K
- Investors: 1
- Date of first sale: 2022-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458351
Issuer
- Name: Noumea Biosciences Inc.
- CIK: 0001944596
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 79 DRESSER ST, BOSTON, MA, 02127
- Phone: 6178039058
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Matthew Blum | Director | Boston, MA |
| Matthew Blum | Executive Officer | Boston, MA |
More